Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2007 2
2008 1
2009 2
2010 1
2012 2
2013 3
2014 5
2015 6
2016 9
2017 9
2018 8
2019 8
2020 8
2021 9
2022 11
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators. Hagström E, et al. Circulation. 2022 Aug 30;146(9):657-672. doi: 10.1161/CIRCULATIONAHA.121.057807. Epub 2022 Jun 30. Circulation. 2022. PMID: 35770629 Free PMC article. Clinical Trial.
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.
Younossi ZM, Blissett D, Blissett R, Henry L, Stepanova M, Younossi Y, Racila A, Hunt S, Beckerman R. Younossi ZM, et al. Hepatology. 2016 Nov;64(5):1577-1586. doi: 10.1002/hep.28785. Epub 2016 Sep 26. Hepatology. 2016. PMID: 27543837
Five models were constructed to estimate the burden of NAFLD in the United States and four European countries. Models were built using a series of interlinked Markov chains, each representing age increments of the NAFLD and the general populations. ...
Five models were constructed to estimate the burden of NAFLD in the United States and four European countries. Models were built using a ser …
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. Ray KK, et al. Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Lancet Diabetes Endocrinol. 2019. PMID: 31272931 Free article. Clinical Trial.
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, Landmesser U, López-Jaramillo P, Manvelian G, Pordy R, Scemama M, Sinnaeve PR, White HD, Gabriel Steg P; ODYSSEY Outcomes Committees and Investigators. Schwartz GG, et al. J Am Coll Cardiol. 2021 Aug 3;78(5):421-433. doi: 10.1016/j.jacc.2021.04.102. J Am Coll Cardiol. 2021. PMID: 34325831 Free PMC article. Clinical Trial.
Cost-Effectiveness in Perioperative Care: Application of Markov Modeling to Pathways of Perioperative Care.
Ludbrook GL, Leaman E. Ludbrook GL, et al. Value Health. 2022 Feb;25(2):215-221. doi: 10.1016/j.jval.2021.07.018. Epub 2021 Sep 10. Value Health. 2022. PMID: 35094794 Free article.
OBJECTIVES: This study aimed to evaluate the application of cost-effectiveness modeling to redesign of perioperative care pathways, from a hospital perspective. METHODS: A Markov cost-effectiveness model of patient transition between care locations, each with different cha …
OBJECTIVES: This study aimed to evaluate the application of cost-effectiveness modeling to redesign of perioperative care pathways, from a h …
Toward a model-based cognitive neuroscience of mind wandering.
Hawkins GE, Mittner M, Boekel W, Heathcote A, Forstmann BU. Hawkins GE, et al. Neuroscience. 2015 Dec 3;310:290-305. doi: 10.1016/j.neuroscience.2015.09.053. Epub 2015 Sep 28. Neuroscience. 2015. PMID: 26427961 Free article. Review.
The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States.
Younossi ZM, Paik JM, Henry L, Yang J, Fernandes G, Stepanova M, Nader F. Younossi ZM, et al. J Clin Exp Hepatol. 2023 May-Jun;13(3):454-467. doi: 10.1016/j.jceh.2022.12.005. Epub 2022 Dec 22. J Clin Exp Hepatol. 2023. PMID: 37250870 Free PMC article.
AIM: Model the burden of NASH in the United States according to obesity. METHODS: The discrete-time Markov model comprised adult NASH subjects moving through 9 health states and 3 absorbing death states (liver, cardiac, and other deaths) with 1-year cycles and a 20-year ho …
AIM: Model the burden of NASH in the United States according to obesity. METHODS: The discrete-time Markov model comprised adult NASH …
Measuring the impact of monoclonal antibody therapies.
Lim KK, Ng K, Balachandran S, Russell MD, Boalch A, Sinclair A, Coker B, Vinnakota K, Mansoor R, Douiri A, Marks LV, Sacks S. Lim KK, et al. Front Med (Lausanne). 2023 Nov 15;10:1256712. doi: 10.3389/fmed.2023.1256712. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38046416 Free PMC article.
RESULTS: Meta-analyses of 27 eligible real-world data (RWD) sets and 26 randomized controlled trial (RCT) sets found close agreement between the observed and expected health outcomes. A Markov model showed the net positive monetary benefit in three Mab regimens and the neg …
RESULTS: Meta-analyses of 27 eligible real-world data (RWD) sets and 26 randomized controlled trial (RCT) sets found close agreement between …
A Markov model simulation of the impact of treatment persistence in postmenopausal osteoporosis.
Cotté FE, Fautrel B, De Pouvourville G. Cotté FE, et al. Med Decis Making. 2009 Jan-Feb;29(1):125-39. doi: 10.1177/0272989X08318461. Epub 2008 Jun 19. Med Decis Making. 2009. PMID: 18566486
BACKGROUND: The Markov model followed a cohort of patients over 10 years to estimate the total number of incident osteoporotic fractures by age for the overall population of women with diagnosed postmenopausal osteoporosis in France (mean age, 71.1 years +/-9.6; range, 50- …
BACKGROUND: The Markov model followed a cohort of patients over 10 years to estimate the total number of incident osteoporotic fractu …
74 results